| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |